FDA approves new drug for leukemia
688289
The Food and Drug Administration approved Clolar, Genzyme Corp.'s new drug for patients under 21 with acute lymphocytic leukemia. An advisory panel on Dec. 1 recommended the drug be approved. Clolar was developed by Ilex Oncology Inc., the Texas firm Cambridge-based Genzyme acquired last week in a $1 billion stock transaction. The FDA panel recommended that more studies be done ...
105288
WASHINGTON -- The Food and Drug Administration yesterday approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone chemotherapy.
668214
WASHINGTON The Food and Drug Administration has approved a drug designed to better fight what&#39;s described as the leading cause of cancer-related deaths in America.
62500
Genzyme Corp. won approval Wednesday for a childhood leukemia drug under an accelerated government approval process for potentially lifesaving treatments.
752431
A panel of medical experts on Wednesday recommended approval for Ilex Oncology Inc.&#39;s (ILXO.O: Quote, Profile, Research) new drug Clolar for use against one type of leukemia but not against another.
440572
The government approved a drug Tuesday that tries a new method of attacking multiple sclerosis, an incurable disease of the central nervous system that affects 350,000 Americans.
287736
TORONTO - A new but potentially costly treatment for multiple sclerosis has received fast-track approval from the US Food and Drug Administration.
340456
A once-a-month drug for treating  multiple sclerosis that appears to cut relapses of the  autoimmune disorder was approved on Tuesday by the U.S. Food  and Drug Administration.
494398
The US Food and Drug Administration on Friday approved a new Purdue Pharma LP opioid-based drug that aims to provide &quot;around-the-clock&quot; relief to patients with moderate to severe pain.
534244
TUESDAY, March 13 (HealthDay News) -- GlaxoSmithKline&#39;s Tykerb (lapatinib) has been approved by the U.S. Food and Drug Administration to treat advanced breast cancer when other cancer drugs haven&#39;t succeeded, the agency said Tuesday.
740280
The Food and Drug Administration approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone chemotherapy.
535223
An experimental drug under development by Bristol-Myers Squibb is showing early promise in reversing the signs and symptoms of patients whose chronic myeloid leukemia failed to respond to Gleevec, which is considered the standard of treatment for the
364386
WEDNESDAY, Jan. 26 (HealthDayNews) -- Scientists have developed a compound that may be able to treat cases of chronic myelogenous leukemia that are resistant to the so-called miracle drug Gleevec.
580950
A panel of medical experts on Wednesday recommended approval for Ilex Oncology&#39;s new drug Clolar for use against one type of leukaemia but not against another.
560148
The Food and Drug Administration approved Clolar, Genzyme Corp.&#39;s new drug for patients under 21 with acute lymphocytic leukemia.
508502
WASHINGTON - The government approved a drug Tuesday that tries a new method of attacking multiple sclerosis, an incurable disease of the central nervous system that affects 350,000 Americans.
412704
NEW YORK (CBS.MW) -- The Food and Drug Administration has approved Genzyme Corp. and Bioenvision Inc.&#39;s treatment for the most common type of childhood leukemia, sending shares of both companies higher Wednesday.